Atlas Trials

A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)

Clinical trial NCT01727271 · WITHDRAWN

Trial details

NCT number
NCT01727271
Sponsor
Merck Sharp & Dohme LLC
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B
Start date
2013-08-01
Primary completion
2017-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.